UnitedHealth Group Incorporated (NYSE:UNH) is identified as one of the most undervalued blue chip stocks to buy by hedge funds. J.P. Morgan analyst Lisa Gill gives UNH an Overweight rating with a $418 price target, suggesting a potential 48% rebound in the next 12 months. The company provides healthcare coverage, data consultancy, and software services through various segments. UnitedHealth Group’s shift to cooperating with the Department of Justice is seen as a defense of its practices, with optimism expressed by analysts. While UNH has investment potential, some AI stocks may offer greater upside with less risk.

Read more at Yahoo Finance: J.P. Morgan Assigns an Overweight Rating to UnitedHealth Group (UNH) With a $418 PT